SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain Pathologies.

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Ascorbic acid (vitamin C) is a vital neuroprotectant.
• Sodium/vitamin C co-transporter isoform 2 (SVCT2) facilitates vitamin C uptake into neurons.
• SVCT2 expression is upregulated in astrocytes under ischemic conditions, suggesting a role in pathological states.

Purpose of the Study:

• To investigate alterations in SVCT2 expression in astrocytes during various neuropathologies.
• To determine if reactive astrogliosis influences SVCT2 expression in the central nervous system (CNS).

Main Methods:

• Induction of neuroinflammation via intracerebroventricular injection of GFP-adenovirus or neuraminidase.
• Assessment of SVCT2 expression in models of traumatic brain injury and epilepsy (kindling model).
• In vitro culture of astrocytes to mimic reactive gliosis.
• Analysis of post-mortem Alzheimer's disease (AD) brain tissue using advanced imaging techniques.

Main Results:

• SVCT2 expression was elevated in astrocytes at sites of neuroinflammation and in models of traumatic injury and epilepsy.
• Cultured astrocytes exhibiting reactive gliosis markers also showed increased SVCT2 expression.
• Notably, SVCT2 expression was absent in astrocytes surrounding amyloid plaques in Alzheimer's disease brains.

Conclusions:

• SVCT2 expression is heterogeneously induced in reactive astrogliosis across different CNS pathologies.
• The absence of SVCT2 in AD-associated reactive astrocytes suggests a unique pathological response.
• Understanding SVCT2 regulation in reactive astrocytes is crucial for neuroprotective strategies.